1 – 15 of 28
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
(
- Contribution to journal › Article
- 2019
-
Mark
Validation of a European Cross-Cultural Neuropsychological Test Battery (CNTB) for evaluation of dementia
(
- Contribution to journal › Article
-
Mark
Validation of the Rowland Universal Dementia Assessment Scale (RUDAS) in a multicultural sample across five Western European countries : diagnostic accuracy and normative data
(
- Contribution to journal › Article
-
Mark
Validation of a brief Multicultural Cognitive Examination (MCE) for evaluation of dementia
(
- Contribution to journal › Article
-
Mark
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE) : a modelling study
(
- Contribution to journal › Article
- 2018
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
(
- Contribution to journal › Article
- 2017
-
Mark
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
(
- Contribution to journal › Article
-
Mark
Association between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals : A Longitudinal Descriptive Cohort Study
(
- Contribution to journal › Article
-
Mark
Cerebrovascular and amyloid pathology in predementia stages : The relationship with neurodegeneration and cognitive decline
(
- Contribution to journal › Article
-
Mark
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers
(
- Contribution to journal › Article
-
Mark
The interactive effect of demographic and clinical factors on hippocampal volume : A multicohort study on 1958 cognitively normal individuals
(
- Contribution to journal › Article
-
Mark
The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes
(
- Contribution to journal › Article
- 2015
-
Mark
DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts.
(
- Contribution to journal › Article
-
Mark
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.
(
- Contribution to journal › Scientific review